Fusion Antibodies Ltd., a Belfast-based developer of antibody therapies for cancer, has raised Gbp1.2 million in second-round funding. Backers include Crescent Capital, Viridian Growth Fund, Quibis Ltd., University Challenge Fund and Invest Northern
Fusion Antibodies Raises Second Round
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.